BioCentury
ARTICLE | Company News

Oscient infectious, metabolic news

June 22, 2009 7:00 AM UTC

In February, Oscient restructured its commercial operations, reduced headcount and retained Broadpoint Capital Inc. to advise on strategic options. At Dec. 31, 2008, Oscient had $17.2 million in cash ...